DOCSLIB.ORG

XB130 Is Overexpressed in Prostate Cancer and Involved in Cell Growth and Invasion

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
XB130 Is Overexpressed in Prostate Cancer and Involved in Cell Growth and Invasion www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 37 Research Paper XB130 is overexpressed in prostate cancer and involved in cell growth and invasion Bin Chen1,2,*, Mengying Liao3,*, Qiang Wei4,*, Feiye Liu5, Qinsong Zeng6, Wei Wang6, Jun Liu6, Jianing Hou7, Xinpei Yu8,9, Jian Liu9 1Department of Science and Training, General Hospital of Guangzhou Military Command of People’s Liberation Army, Guangzhou, Guangdong, China 2Guangzhou Huabo Biopharmaceutical Research Institute, Guangzhou, Guangdong, China 3Department Of Pathology, Peking University Shenzhen Hospital, Shenzhen, China 4Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China 5Cancer Center, Traditional Chinese Medicine-Integrated Hospital of Southern Medical University, Guangzhou, Guangdong, China 6Department of Urology, General Hospital of Guangzhou Military Command of People’s Liberation Army, Guangzhou, Guangdong, China 7Sun Yat-Sen University, Guangzhou, China 8Guangdong Provincial Key Laboratory of Geriatric Infection and Organ Function Support and Guangzhou Key Laboratory of Geriatric Infection and Organ Function Support, Guangzhou, Guangdong, China 9Center for Geriatrics, General Hospital of Guangzhou Military Command of People’s Liberation Army, Guangzhou, Guangdong, China *These authors contributed equally to this work Correspondence to: Xinpei Yu, email: [email protected] Jian Liu, email: [email protected] Keywords: XB130, adaptor protein, proliferation, invasion, Akt Received: January 27, 2016 Accepted: June 29, 2016 Published: August 05, 2016 ABSTRACT XB130 is a cytosolic adaptor protein involved in various physiological processes and oncogenesis of certain malignancies, but its role in the development of prostate cancer remains unclear. In current study, we examined XB130 expression in prostate cancer tissues and found that XB130 expression was remarkably increased in prostate cancer tissues and significantly correlated with increased prostate specific antigen (PSA), free PSA (f-PSA), prostatic acid phosphatase (PAP) and T classification. Patients with highly expressed XB130 had significantly decreased survival, which suggested XB130 as a possible prognostic indicator for prostate cancer. In vitro experiments showed that reduced XB130 expression restrained tumor growth both in vitro and in vivo. Furthermore, XB130 knockdown hindered transition of G1 to S phase in prostate cancer cell line DU145 and LNCap, which might contribute to the inhibition of cellular proliferation. Results from transwell assay demonstrated that downregulation of XB130 may attenuate invasion and metastasis of prostate cancer. Semiquantitative analysis of Western blot suggested that decreased XB130 expression was accompanied by diminished Akt signaling and EMT process. Thus, above observations suggest that XB130 may be a novel molecular marker and potent therapeutic target for prostate cancer. INTRODUCTION cancer with a low specificity of 18.67%–30.08% as single use in for biopsy [3]. To clarify the molecular mechanism Prostate cancer is the most common and second involved in prostate cancer is of great importance for lethal cancer in western male population [1, 2]. PSA is finding a potent and more effective diagnostic marker and the major significant marker for the diagnosis of prostate improving the treatment of prostate cancer. www.impactjournals.com/oncotarget 59377 Oncotarget Adaptor protein has a unique modular structure XB130 knockdown suppresses growth of prostate without enzymatic activity, which can be regulated by cancer in vitro multiple signaling. It consists of actin filament associated protein (AFAP), Src interacting/Signal integrating protein XB130 mRNA (Figure 2A) and protein (Figure 2B) (Sin) and Crk-associated substrate (CAS). Multiple studies levels were detected in prostate cancer cell line 22RV1, have proved this functions in mitosis, differentiation, LNCap, DU145, PC3, which showed that XB130 inflammation, cell survival, movement, and adhesion expressed in four prostate cancer cell lines at different through binding SH3 and SH2 domains and activating c-Src levels. DU145 and LNCap expressed more XB130 in four [4–6]. AFAP, as a small adaptor protein, is involved in cell prostate cancer cell lines than 22RV1 and PC3, thus were signal transduction, assembling of cell cytoskeleton and chosen for further knockdown studies. other cell functions, which can directly induce activation of To explore the effect of XB130 on proliferation c-Src by mechanical stretch. XB130, also named AFAP1L-2, of prostate cancer, we established two cell lines with is a 130kDa adaptor protein with 818 amino acids located downregulated XB130 expression and named as DU145/ on chromosome 10q25.3 [7]. As the substrate and regulator XB130- and LNCap/XB130-, while control cell lines of signal transduction mediated by tyrosine kinases, XB130 were DU145/mock and LNCap/mock (Figure 2C). CCK8 phosphorylates tyrosine through SH2 and SH3 domains at assay (Figure 2D) showed that proliferation of DU145/ the N-terminal of Src [8]. The role of XB130 varies in cell XB130- was significantly slower than DU145/mock cells proliferation, survival, movement and invasion in different (F = 34.988, p = 0.02). Similar disparity was seen in malignancies [9–11]. In thyroid carcinoma, aberrant XB130 LNCap/XB130- cells (Figure 2D, F = 43.644, P = 0.000). expression induces cell death and enhances apoptosis [12]. Colony formation assay (Figure 3A and 3B) indicated that, Interestingly, high XB130 protein level improves survival knockdown of XB130 in DU145 (F = 95.663, p = 0.000) and sensitivity to 5-Fluorouracil in gastric cancer patients and LNCap (F = 92.789, p = 0.000) could suppress the [13] while correlates with higher pathological grade and formation of colony of both groups comparing to DU145/ poorer prognosis of pancreatic ductal carcinoma [14]. Thus mock and LNCap/mock. Downregulation of XB130 the association between XB130 and prostate cancer are resulted in repression of colony formation by nearly worthy to be explored. Our previous findings demonstrated 84% and 89% in DU145 and LNCap, respectively. that low to moderate XB130 expression were seen in normal, Thus, decreased XB130 led to inhibitive proliferation of hyperplastic and peritumoral prostate tissues, while elevated prostate cancer cell lines, which supported our previous XB130 expression was displayed in prostate cancer tissues conclusion that strong XB130 expression enhanced the (Data not shown), but whether XB130 can affect cellular growth of prostate cancer. In flow cytometry analysis growth and invasion in prostate cancer is unclear. Thus in (Figure 3C and 3D), DU145/XB130- (23.05% vs 26.92%, present study, we further investigated the linkage between p = 0.04) and LNCap/XB130- (18.86% vs 24.12%, XB130 and prognosis of prostate cancer and effects of p = 0.03) displayed strikingly shorter S phase than control XB130 on proliferation, invasion and metastasis of prostate cells. Although not statistically significant, G1 phase cancer cells. prolongation were shown in DU145/XB130- (66.16% vs 56.43%, p = 0.2) and LNCap/XB130- cells (70.45% vs RESULTS 65.43%, p = 0.3), which suggested that decreasing XB130 might subdue the transition of G1 to S phase in prostate XB130 is a novel prognostic indicator for cancer, which might be a cause for the restrain of cellular prostate cancer proliferation. We first examined XB130 expression in 210 cases XB130 knockdown inhibits tumor growth in vivo of prostate cancer with pathological diagnosis. Consistent with our previous findings (data not shown), XB130 We also investigated the effect of XB130 on the expression was remarkably increased in prostate cancer tumor growth using xenograft model in nude mice. Six days tissues as compared with hyperplastic and normal tissues after subcutaneous injection of 107 cells on the back of nude (Figure 1A). As Table 1 indicated, XB130 was positively mice, we started to assess the tumor growth by measuring expressed in 85.6% specimens and significantly correlated the tumor size when apparent tumors were seen on the back with increased prostate specific antigen (PSA) (p = 0.006), of mice. The tumor formation in the XB130 knockdown free PSA (f-PSA) (p = 0.036), prostatic acid phosphatase groups was significantly slower than in control groups. The (PAP) (p = 0.02) and T classification (p = 0.025). Kaplan– tumors of knockdown groups were strikingly smaller when Meier analysis (Figure 1B) revealed that patients with compared with control groups at day 18 and the difference highly expressed XB130 have significantly decreased became significant at day 21 after injection. As indicated in survival rate than those with lower XB130 expression Figure 4A and 4B, remarkable suppression of tumor size (p = 0.0121), which indicated that XB130 expression was and volume was seen in xenografts from DU145/XB130- inversely correlated with survival in prostate cancer. (p = 0.03) and LNCap/XB130- (p = 0.02) when compared www.impactjournals.com/oncotarget 59378 Oncotarget Table 1: Relation between XB130 expression and clinicopathologic variables inprostate cancer patients variables low expression high expression total t/χ2 P gleason 6.24 ± 1.84 7.04 ± 1.51 –3.295 0.001 PSA 43.08 ± 68.68 79.39 ± 143.15 0.006 f-PSA 8.71 ± 13.70 15.20 ± 22.80 0.036 T classification 1 11 (17.2%) 8 (5.5%) 19 (9.1%) 9.356 0.025 2 37 (57.8%) 102 (70.3%) 139 (66.5%) . 3 8 (12.5%) 11 (7.6%) 19 (9.1%) . 4 8 (12.5%) 24 (16.6%) 32 (15.3%) . PAP 1 6 (9.7%) 4 (2.7%) 10 (4.8%) 7.866 0.02
Load more

Recommended publications
  • Gene Section Review
    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL INIST -CNRS Gene Section Review AFAP1L2 (actin filament associated protein 1- like 2) Xiaohui Bai, Serisha Moodley, Hae-Ra Cho, Mingyao Liu Latner Thoracic Surgery Research Laboratoires, University Health Network, Toronto General Research Institute, University of Toronto, Toronto, Ontario, Canada (XB, SM, HRC, ML) Published in Atlas Database: January 2014 Online updated version : http://AtlasGeneticsOncology.org/Genes/AFAP1L2ID52197ch10q25.html DOI: 10.4267/2042/54026 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2014 Atlas of Genetics and Cytogenetics in Oncology and Haematology Abstract Identity Review on AFAP1L2, with data on DNA/RNA, on Other names: KIAA1914, XB130 the protein encoded and where the gene is HGNC (Hugo): AFAP1L2 implicated. Location: 10q25.3 Figure 1. XB130 chromosomal location and neighbour genes. A. xb130 gene is located on chromosome 10, at 10q25.3 by fluorescence in situ hybridization (FISH). B. Diagram of xb130 neighbour genes between 115939029 and 116450393. Atlas Genet Cytogenet Oncol Haematol. 2014; 18(9) 628 AFAP1L2 (actin filament associated protein 1-like 2) Bai X, et al. Figure 2. XB130 functional domains and motifs. Human XB130 has 818 amino acids. It contains the following motif/domains: proline-rich region: residues 98-107; tyrosine phosphorylation motif: residues 54-57, 124-127; 148-151; 457-460; PH domain: residues 175-272; 353-445; coiled-coil region: residues 652-749. approximately 130 kDa by western blotting (Xu et DNA/RNA al., 2007). As an adaptor protein, XB130 has no Note enzymatic domains or activity.
    [Show full text]
  • XB130: in Silico and in Vivo Studies of a Novel Signal Adaptor Protein
    XB130: in silico and in vivo studies of a novel signal adaptor protein By Matthew Rubacha A thesis submitted in conformity with the requirements for the degree of Master of Science Department of Physiology University of Toronto © Copyright by Matthew Rubacha 2009 Library and Archives Bibliothèque et Canada Archives Canada Published Heritage Direction du Branch Patrimoine de l’édition 395 Wellington Street 395, rue Wellington Ottawa ON K1A 0N4 Ottawa ON K1A 0N4 Canada Canada Your file Votre référence ISBN: 978-0-494-59565-7 Our file Notre référence ISBN: 978-0-494-59565-7 NOTICE: AVIS: The author has granted a non- L’auteur a accordé une licence non exclusive exclusive license allowing Library and permettant à la Bibliothèque et Archives Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par télécommunication ou par l’Internet, prêter, telecommunication or on the Internet, distribuer et vendre des thèses partout dans le loan, distribute and sell theses monde, à des fins commerciales ou autres, sur worldwide, for commercial or non- support microforme, papier, électronique et/ou commercial purposes, in microform, autres formats. paper, electronic and/or any other formats. The author retains copyright L’auteur conserve la propriété du droit d’auteur ownership and moral rights in this et des droits moraux qui protège cette thèse. Ni thesis. Neither the thesis nor la thèse ni des extraits substantiels de celle-ci substantial extracts from it may be ne doivent être imprimés ou autrement printed or otherwise reproduced reproduits sans son autorisation.
    [Show full text]
  • Stimulus-Dependent Dissociation Between XB130 and Tks5 Scaffold Proteins Promotes Airway Epithelial Cell Migration
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 47 Research Paper: Pathology Stimulus-dependent dissociation between XB130 and Tks5 scaffold proteins promotes airway epithelial cell migration Serisha Moodley1,2, Mathieu Derouet2, Xiao Hui Bai2, Feng Xu3, Andras Kapus1,4, Burton B. Yang1,5 and Mingyao Liu1,2 1 Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Canada 2 Latner Thoracic Surgery Research Laboratories, Toronto General Research Institute, University Health Network, Toronto, Canada 3 Advanced Optical Microscopy Facility, UHN, Toronto, Canada 4 Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, Canada 5 Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Canada Correspondence to: Mingyao Liu, email: [email protected] Keywords: actin filament associate protein 1-like 2, SH3PXD2A, lamellipodia, podosomes, lung repair, Pathology Section Received: August 26, 2016 Accepted: November 02, 2016 Published: November 09, 2016 ABSTRACT Repair of airway epithelium after injury requires migration of neighboring epithelial cells to injured areas. However, the molecular mechanisms regulating airway epithelial cell migration is not well defined. We have previously shown that XB130, a scaffold protein, is required for airway epithelial repair and regeneration in vivo, and interaction between XB130 and another scaffold protein, Tks5, regulates cell proliferation and survival in human bronchial epithelial cells. The objective of the present study was to determine the role of XB130 and Tks5 interaction in airway epithelial cell migration. Interestingly, we found that XB130 only promotes lateral cell migration, whereas, Tks5 promotes cell migration/invasion via proteolysis of extracellular matrix. Upon stimulation with EGF, PKC activator phorbol 12, 13-dibutyrate or a nicotinic acetylcholine receptor ligand, XB130 and Tks5 translocated to the cell membrane in a stimulus-dependent manner.
    [Show full text]
  • RET Gene Fusions in Malignancies of the Thyroid and Other Tissues
    G C A T T A C G G C A T genes Review RET Gene Fusions in Malignancies of the Thyroid and Other Tissues Massimo Santoro 1,*, Marialuisa Moccia 1, Giorgia Federico 1 and Francesca Carlomagno 1,2 1 Department of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, 80131 Naples, Italy; [email protected] (M.M.); [email protected] (G.F.); [email protected] (F.C.) 2 Institute of Endocrinology and Experimental Oncology of the CNR, 80131 Naples, Italy * Correspondence: [email protected] Received: 10 March 2020; Accepted: 12 April 2020; Published: 15 April 2020 Abstract: Following the identification of the BCR-ABL1 (Breakpoint Cluster Region-ABelson murine Leukemia) fusion in chronic myelogenous leukemia, gene fusions generating chimeric oncoproteins have been recognized as common genomic structural variations in human malignancies. This is, in particular, a frequent mechanism in the oncogenic conversion of protein kinases. Gene fusion was the first mechanism identified for the oncogenic activation of the receptor tyrosine kinase RET (REarranged during Transfection), initially discovered in papillary thyroid carcinoma (PTC). More recently, the advent of highly sensitive massive parallel (next generation sequencing, NGS) sequencing of tumor DNA or cell-free (cfDNA) circulating tumor DNA, allowed for the detection of RET fusions in many other solid and hematopoietic malignancies. This review summarizes the role of RET fusions in the pathogenesis of human cancer. Keywords: kinase; tyrosine kinase inhibitor; targeted therapy; thyroid cancer 1. The RET Receptor RET (REarranged during Transfection) was initially isolated as a rearranged oncoprotein upon the transfection of a human lymphoma DNA [1].
    [Show full text]
  • Supplementary Material
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Page 1 / 45 SUPPLEMENTARY MATERIAL Appendix A1: Neuropsychological protocol. Appendix A2: Description of the four cases at the transitional stage. Table A1: Clinical status and center proportion in each batch. Table A2: Complete output from EdgeR. Table A3: List of the putative target genes. Table A4: Complete output from DIANA-miRPath v.3. Table A5: Comparison of studies investigating miRNAs from brain samples. Figure A1: Stratified nested cross-validation. Figure A2: Expression heatmap of miRNA signature. Figure A3: Bootstrapped ROC AUC scores. Figure A4: ROC AUC scores with 100 different fold splits. Figure A5: Presymptomatic subjects probability scores. Figure A6: Heatmap of the level of enrichment in KEGG pathways. Kmetzsch V, et al. J Neurol Neurosurg Psychiatry 2021; 92:485–493. doi: 10.1136/jnnp-2020-324647 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Appendix A1. Neuropsychological protocol The PREV-DEMALS cognitive evaluation included standardized neuropsychological tests to investigate all cognitive domains, and in particular frontal lobe functions. The scores were provided previously (Bertrand et al., 2018). Briefly, global cognitive efficiency was evaluated by means of Mini-Mental State Examination (MMSE) and Mattis Dementia Rating Scale (MDRS). Frontal executive functions were assessed with Frontal Assessment Battery (FAB), forward and backward digit spans, Trail Making Test part A and B (TMT-A and TMT-B), Wisconsin Card Sorting Test (WCST), and Symbol-Digit Modalities test.
    [Show full text]
  • Original Article Expression of XB130 in Human Ductal Breast Cancer
    Int J Clin Exp Pathol 2015;8(5):5300-5308 www.ijcep.com /ISSN:1936-2625/IJCEP0006785 Original Article Expression of XB130 in human ductal breast cancer Jiacun Li1, Wanli Sun1, Hui Wei2, Xiurong Wang3, Hongjun Li1, Zhengjun Yi1 1Department of Clinical Laboratory, The Affiliated Hospital of Weifang Medical College, Weifang, China; 2Department of Hepatobiliary Surgery,The People’s Hospital of Zhangqiu, Jinnan, China; 3Department of Ultrasonography, The People’s Hospital of Zhangqiu, Jinnan, China Received February 6, 2015; Accepted March 30, 2015; Epub May 1, 2015; Published May 15, 2015 Abstract: Objectives: XB130 is involved in gene regulation, cell proliferation, cell survival, cell migration, and tu- morigenesis. In the present study, we first evaluated the expression of the XB130 and its prognostic significance in breast cancer. Then we evaluated whether XB130 could be a target for therapy in breast cancer. Materials and methods: Immunohistochemistry was used to assess the level of XB130 protein in surgically resected, formalin- fixed, paraffin-embedded breast cancer specimens. Associations between XB130 and the postoperative prognosis of patients with breast cancer were evaluated. We evaluated the effect of XB130 inhibited by RNA interference on proliferation, invasion and apoptosis in vitro in a metastatic subclone of MCF-7 breast cancer cell line (LM-MCF-7). The effect of XB130 silencing alone or in combination with gemcitabine on LM-MCF-7 cells apoptosis was also investigated. Results: XB130 protein was present in the cytoplasm of malignant cells, and not in the normal breast tissues. There was correlation between the presence of XB130 in tumour cells and lymph node status, tumor clas- sification and clinical stage.
    [Show full text]
  • Actin Filament-Associated Protein 1-Like 1 Mediates Proliferation And
    LAB/IN VITRO RESEARCH e-ISSN 1643-3750 © Med Sci Monit, 2018; 24: 215-224 DOI: 10.12659/MSM.905900 Received: 2017.06.24 Accepted: 2017.07.17 Actin Filament-Associated Protein 1-Like 1 Published: 2018.01.11 Mediates Proliferation and Survival in Non- Small Cell Lung Cancer Cells Authors’ Contribution: ABE 1,2 Meng Wang 1 Graduate School, Tianjin Medical University, Tianjin, P.R. China Study Design A D 2 Xingpeng Han 2 Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin, P.R. China Data Collection B 3 Department of Respiratory and Critical Care Medicine, Tianjin Chest Hospital, Statistical Analysis C B 2 Wei Sun Tianjin, P.R. China Data Interpretation D C 2 Xin Li Manuscript Preparation E F 3 Guohui Jing Literature Search F Funds Collection G AG 2 Xun Zhang Corresponding Author: Xun Zhang, e-mail: [email protected] Source of support: Departmental sources Background: The actin filament-associated protein (AFAP) family consists of 3 novel adaptor proteins: AFAP1, AFAP1L1, and AFAP1L2/XB130. Although evidence shows that AFAP1 and AFAP1L2 play an oncogenic role, the effect of AFAP1L1 on tumor cell behavior has not been fully elucidated, and it remains unknown whether AFAP1L1 could be a prognostic marker and/or therapeutic target of lung cancer. Material/Methods: Human A549 non-small cell lung cancer (NSCLC) cells were used in this study. AFAP1L1 gene was knocked down by AFAP1L1 short hairpin RNA (shRNA) transfection. Cell proliferation was analyzed using Celigo image cytom- etry and MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay, cell cycle progression was assessed with flow cytometry, and cell apoptosis was determined by flow cytometry after annexin-n staining.
    [Show full text]
  • XB130 Mediates Cancer Cell Proliferation and Survival Through Multiple Signaling Events Downstream of Akt
    XB130 Mediates Cancer Cell Proliferation and Survival through Multiple Signaling Events Downstream of Akt Atsushi Shiozaki1, Grace Shen-Tu1, Xiaohui Bai1, Daisuke Iitaka1, Valentina De Falco3, Massimo Santoro3, Shaf Keshavjee1,2, Mingyao Liu1,2* 1 Latner Thoracic Surgery Research Laboratories, University Health Network Toronto General Research Institute, Toronto, Ontario, Canada, 2 Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada, 3 Dipartimento di Biologia e Patologia Cellulare e Molecolare, Istituto di Endocrinologia ed Oncologia Sperimentale del CNR ‘G. Salvatore’, Naples, Italy Abstract XB130, a novel adaptor protein, mediates RET/PTC chromosome rearrangement-related thyroid cancer cell proliferation and survival through phosphatidyl-inositol-3-kinase (PI3K)/Akt pathway. Recently, XB130 was found in different cancer cells in the absence of RET/PTC. To determine whether RET/PTC is required of XB130-related cancer cell proliferation and survival, WRO thyroid cancer cells (with RET/PTC mutation) and A549 lung cancer cells (without RET/PTC) were treated with XB130 siRNA, and multiple Akt down-stream signals were examined. Knocking-down of XB130 inhibited G1-S phase progression, and induced spontaneous apoptosis and enhanced intrinsic and extrinsic apoptotic stimulus-induced cell death. Knocking- down of XB130 reduced phosphorylation of p21Cip1/WAF1, p27Kip1, FOXO3a and GSK3b, increased p21Cip1/WAF1protein levels and cleavages of caspase-8 and-9. However, the phosphorylation of FOXO1 and the protein levels of p53 were not affected by XB130 siRNA. We also found XB130 can be phosphorylated by multiple protein tyrosine kinases. These results indicate that XB130 is a substrate of multiple protein tyrosine kinases, and it can regulate cell proliferation and survival through modulating selected down-stream signals of PI3K/Akt pathway.
    [Show full text]
  • XB130 Enhances Invasion and Migration of Human Colorectal Cancer Cells by Promoting Epithelial‑Mesenchymal Transition
    5592 MOLECULAR MEDICINE REPORTS 16: 5592-5598, 2017 XB130 enhances invasion and migration of human colorectal cancer cells by promoting epithelial‑mesenchymal transition JIANCHENG SHEN1*, CHANG'E JIN2*, YONGLIN LIU3, HEPING RAO4, JINRONG LIU5 and JIE LI6 1Clinical Laboratory, Shaoxing Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang 312499; 2Intensive Care Unit, Laigang Hospital Affiliated to Taishan Medical University, Laiwu, Shandong 272009; 3Clinical Laboratory, Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang 310002; 4Department of Nursing, School of Medicine, Quzhou College of Technology, Quzhou, Zhejiang 324000; 5Department of Child Healthcare; 6Department of Infectious Disease, Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, P.R. China Received October 16, 2016; Accepted June 8, 2017 DOI: 10.3892/mmr.2017.7279 Abstract. The expression of XB130 is associated with inva- result of EMT inhibition. Thus, upregulation of XB130 may sion and migration of many tumor cells, but its roles in human underlie some of the tumorigenic events observed in human colorectal cancer (CRC) remains unknown. To investigate this, CRCs. XB130 may be a promising target for CRC therapy in protein expression levels of XB130 in numerous human CRC humans; further mechanistic studies exploring the function of cell lines were compared with a normal colorectal mucosa cell XB130 in CRC cells are warranted. line by western blotting. Knockdown of XB130 using small interfering (si)RNA was performed to assess the effects on cell Introduction invasion and migration in a Transwell assay and a scratch test. Western blotting was also used to quantify the levels of proteins Colorectal cancer (CRC) is one of the most common malig- associated with epithelial-mesenchymal transition (EMT), nancies in the world, accounting for 10% of all cancers (1,2).
    [Show full text]
  • A New Member of the AFAP Family, AFAP1L1, Binds to Cortactin and Localizes to Invadosomes
    Graduate Theses, Dissertations, and Problem Reports 2011 A New Member of the AFAP Family, AFAP1L1, Binds to Cortactin and Localizes to Invadosomes Brandi Nicole Snyder West Virginia University Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Snyder, Brandi Nicole, "A New Member of the AFAP Family, AFAP1L1, Binds to Cortactin and Localizes to Invadosomes" (2011). Graduate Theses, Dissertations, and Problem Reports. 3379. https://researchrepository.wvu.edu/etd/3379 This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. A New Member of the AFAP Family, AFAP1L1, Binds to Cortactin and Localizes to Invadosomes Brandi Nicole Snyder Dissertation submitted to the School of Medicine at West Virginia University in partial fulfillment of the requirements for the degree of Doctor of Philosophy In Cancer Cell Biology
    [Show full text]
  • XB130 Promotes Proliferation and Invasion of Gastric Cancer Cells
    Shi et al. Journal of Translational Medicine 2014, 12:1 http://www.translational-medicine.com/content/12/1/1 RESEARCH Open Access XB130 promotes proliferation and invasion of gastric cancer cells Min Shi1†, Dayong Zheng1†, Li Sun1, Lin Wang1, Li Lin1, Yajun Wu1, Minyu Zhou1, Wenjun Liao1, Yulin Liao2, Qiang Zuo1* and Wangjun Liao1* Abstract Background: XB130 has been reported to be expressed by various types of cells such as thyroid cancer and esophageal cancer cells, and it promotes the proliferation and invasion of thyroid cancer cells. Our previous study demonstrated that XB130 is also expressed in gastric cancer (GC), and that its expression is associated with the prognosis, but the role of XB130 in GC has not been well characterized. Methods: In this study, we investigated the influence of XB130 on gastric tumorigenesis and metastasis in vivo and in vitro using the MTT assay, clonogenic assay, BrdU incorporation assay, 3D culture, immunohistochemistry and immunofluorescence. Western blot analysis was also performed to identify the potential mechanisms involved. Results: The proliferation, migration, and invasion of SGC7901 and MNK45 gastric adenocarcinoma cell lines were all significantly inhibited by knockdown of XB130 using small hairpin RNA. In a xenograft model, tumor growth was markedly inhibited after shXB130-transfected GC cells were implanted into nude mice. After XB130 knockdown, GC cells showed a more epithelial-like phenotype, suggesting an inhibition of the epithelial-mesenchymal transition (EMT) process. In addition, silencing of XB130 reduced the expression of p-Akt/Akt, upregulated expression of epithelial markers including E-cadherin, α-catenin and β-catenin, and downregulated mesenchymal markers including fibronectin and vimentin.
    [Show full text]
  • Review Article XB130—A Novel Adaptor Protein: Gene, Function, and Roles in Tumorigenesis
    Hindawi Publishing Corporation Scientifica Volume 2014, Article ID 903014, 9 pages http://dx.doi.org/10.1155/2014/903014 Review Article XB130—A Novel Adaptor Protein: Gene, Function, and Roles in Tumorigenesis Xiao-Hui Bai,1 Hae-Ra Cho,1,2 Serisha Moodley,1,3 and Mingyao Liu1,2,3,4 1 Latner Thoracic Surgery Research Laboratories, Toronto General Research Institute, University Health Network, 101 College Street, Toronto,ON,CanadaM5G1L7 2 Department of Physiology, Faculty of Medicine, University of Toronto, 1 King’s College Circle, Toronto,ON,CanadaM5S1A8 3 Institute of Medical Science, Faculty of Medicine, University of Toronto, 1 King’s College Circle, Toronto, ON, Canada M5S 1A8 4 Department of Surgery, Faculty of Medicine, University of Toronto, 149 College Street, Toronto, ON, Canada M5T 1P5 Correspondence should be addressed to Mingyao Liu; [email protected] Received 10 February 2014; Accepted 15 May 2014; Published 5 June 2014 Academic Editor: Patrick Auberger Copyright © 2014 Xiao-Hui Bai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Several adaptor proteins have previously been shown to play an important role in the promotion of tumourigenesis. XB130 (AFAP1L2) is an adaptor protein involved in many cellular functions, such as cell survival, cell proliferation, migration, and gene and miRNA expression. XB130’s functional domains and motifs enable its interaction with a multitude of proteins involved in several different signaling pathways. As a tyrosine kinase substrate, tyrosine phosphorylated XB130 associates with thep85 regulatory subunit of phosphoinositol-3-kinase (PI3K) and subsequently affects Akt activity and its downstream signalling.
    [Show full text]